Ignite Creation Date:
2024-07-17 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06476210
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-06-14
Brief Title:
The Safety and Efficacy of BDLBedaquiline Plus Delamanid Plus Linezolid Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis MDR-TB or Rifampicin-Resistant Tuberculosis RR-TB
Sponsor:
Beijing Chest Hospital
Organization:
Beijing Chest Hospital
Organization Data
Organization:
Beijing Chest Hospital
Class:
OTHER
Study ID:
YNLX-2024-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Chest Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Public Health Clinical Medical Center of Chengdu | UNKNOWN |
| Wuhan Institute for Tuberculosis Control | OTHER |
| Changsha Central Hospital | OTHER |
| Anhui Chest Hospital | OTHER |
| Hunan Chest Hospital | UNKNOWN |
| Shandong Public Health Clinical Center | OTHER_GOV |